AzTrials
AzTrials

Type 1 DiabetesNCT02914496

ACT Stress Management in Type 1 Diabetes

A study testing Acceptance and Commitment Therapy (ACT) in people with Type 1 Diabetes, run by Karolinska Institutet at 1 site in Sweden.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

For many people living with type 1 diabetes it is a challenge to achieve good glucose control. Barely 20% reaches the goal level and many people experience self-care as complex, demanding and stressful. Read more about this study

Who is it for?
Ages 18 to 70 years
Conditions the study is for
Type 1 Diabetes
What is being tested?
Acceptance and Commitment Therapy (ACT)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
81 participants
Where
1 siteSweden
Study dates
15 Oct 2016to 31 Dec 2025
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 70 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Type 1 diabetes
  • Duration of disease >2 years -
  • Hb1c>60 mmol/mol

Who cannot join

  • Insufficient knowledge to understand and express themselves in Swedish
  • Untreated or severe ongoing psychiatric disease
  • Cortisone treatment
  • Untreated thyroid disease
  • Insulin pump therapy started since <3 months

Trial locations and contacts

1 site in 1 country.

Sweden1 site
  • Ersta sjukhus

    Stockholm, Stockholm County, 11691

Other trials in Sweden

About this study

Official title: "Diabetes in Balance" - a Randomized Controlled Trial to Evaluate the Effects on Glucose Control, Self-care and Psychosocial Factors?

For many people living with type 1 diabetes it is a challenge to achieve good glucose control. Barely 20% reaches the goal level and many people experience self-care as complex, demanding and stressful. The purpose of this study is to evaluate the effect of a stress-management program on glucose control, self-care and psychosocial factors. The program is based on Acceptance and Commitment Therapy (ACT), a specific form of Cognitive behavior therapy (CBT). A total of 70 adult patients with type 1 diabetes from Ersta hospital will be recruited. Half of them will receive the intervention and the other half will continue with their regular diabetes care. A licensed psychologist specialised in CBT and a diabetes specialist nurse will be leading the intervention that is given in a group format. The program consists of seven 2-hour sessions given over 14 weeks. Glucose control, self care and stress will be measured at inclusion, after session four and seven, at six , 12 and 24 months and finally after 5 years

Read the detailed description

ACT-stress management in type 1 diabetes - a randomized controlled trial to evaluate the effect on glucose control, self-control and psychosocial factors.

Purpose of proposed investigation:

The project hypothesis are that the CBT-intervention will a) improve glucose control, self-care, quality of life and acceptance of diabetes related thoughts and emotions and b) decrease depression, anxiety, general and diabetes related distress and fear of hypoglycemia.

Background information for the project:

The overall goal of diabetes management is to achieve good glycemic control while still maintaining good quality of life and experiencing as few hypoglycemic episodes as possible (the Swedish Social Board of Welfare, 2010). Currently only 19% of people with diabetes reach the goal of 52 mmol/mol for glycemic control (National Diabetes Registry, 2014). Research has proposed difficulties with behavior change (Knight et al., 2006), diabetes related distress (van Bastelar et al., 2010, Fisher et al., 2010) and fear of hypoglycemia (Wild et al., 2007) as important obstacles in achieving the goal. Patient education plays an important role in diabetes care but may not be sufficient in order to reach the recommended treatment goals. The association between knowledge and behavior change is weak and research has suggested that interventions should be more behavior oriented (Knight et al., 2006, Funnell et al., 2008). It is well known that people with chronic disease have an increased risk of developing psychological problems, for instance there are studies showing up to four times higher prevalence of depression in people with type 1 diabetes (Roy \& Lloyd, 2012). It is also known that psychological problems are associated with poorer glycemic control, health and quality of life in this group (Chiechanowski et al., 2000; Jacobson, 2004).

Therefore, it is urgent to quickly discover and treat psychological problems. There is scientific support for Cognitive Behavior Therapy (CBT) to be effective in treating different types of anxiety (Stewart \& Chambless, 2009) and depression (Cuijpers et al., 2011).

In light of this, different CBT-based interventions have been suggested as promising alternatives in treating diabetes. Several programs based on CBT have also been scientificly evaluated. Some of these studies have focused on changing concrete every day behaviors in order to promote self-care, glycemic control and quality of life (Snoek et al., 2008, Amsberg et al., 2009a,b) and some to treat co-morbid depression (Lustman et al., 1998). Our previous intervention study in this field (Amsberg et al., 2009 a, b) was the first one to show significant positive effects on glycemic control. In recent years a new form of CBT, Acceptance and Commitment Thearpy, (ACT), (Hayes, Strosahl, \& Wilson, 1999) has received scientific attention. Of particular interest is that relatively short ACT-interventions in several studies have shown good results in a wide variety of psychosocial problems, smoking cessation, work related stress, anxiety, depression, chronic pain, epilepsi (Hayes et al., 2006).

" ACT-stressmanagement" is an intervention originally developed for preventing work-related stress and illness (Bond \& Bunce, 2003) that later has been modified for different groups of peopel such as high-school students (Livheim, 2004), social workers (Brinkborg et al., 2011), medical students (Andersson \& Waller, 2011). The intervention is designed so that different types of professionals, not only psychologists, can serve as group-leaders after a short period of training.

Plan of investigation:

The intervention "ACT-stress-management" will in this study be given as a course consisting of seven sessions where each session is two hours long. The course has been modified for people with diabetes so that the excercises and information will be related to diabetes and diabetes related problems. The sessions will be held every other week. The groups will consist of between six to a maximum of ten participants.

Subjects Inclusion criteria will be all adult (18-70 years) type 1 diabetes patients with HbA1c > 60 mmol/mol registered at Ersta hospital, diabetes- and endochrinology department/unit. The patient must be able to read, write and speak Swedish. Those with severe psychiatric conditions such as psychosis, recurrent severe depression or post-traumatic stress disorder, those with an ongoing cortison treatment, with co-morbid severe illness that affects glycemic control or are pregnant will be excluded.

Power-calculation:

A total of 56 patients (28 in the intervention group and 28 in the control group) are needed to achieve 80% power to detect the clinically relevant decrease of 6 mmol (The Association of Physical Activity, 2015) in HbA1c with 5% significance level and an SD of 9 mmol. In order to take in account of a drop-out rate of 24 % (Amsberg et al., 2008) during the study a total of 70 patients are needed to be included. The power-calculation was done with a web-based power-caculator.

Procedure:

The study consists of five main steps: 1. Recruitment of participants 2. The intervention 3. Psychometric evaluation of the Swedish version of AADQ 4. Data-processing 5. Presentation of the results

  1. Recruitment of participants We will recruit a total of 70 patients during 2-3 years, of which half will receive the "ACT-stress-management" program and half will continue with treatment as usual. Patients fulfilling the inclusion criteria will meet the person collecting the data at the diabetes-center in order to receive information of the study and will at the same time be asked to participate in the study. At this time the participants will be informed orally and in writing about the study, recieve information about their possibility to leave the study at any time without any consequences, how data will be handled and finally about receiving a compensation in the form of a gift voucher of 100 SEK after each time they complete a set of questionnaires.
  2. The intervention The intervention consists of: "The ACT-stressmanagement" intervention and administrating pre-intervention measurements, processmeasurments, post-intervention measurements and follow-up measurements. The control-group will only consist of the pre-, process-, post and follow-up measurements.

The intervention-group:

  1. Informed consent for the study
  2. After agreeing to being included, participants complete the set of questionnaires for base-line measures
  3. "the ACT-stressmanagement" is given, including two process-measurements of AADQ
  4. Post-intervention measurments
  5. 1-year post inclusion follow-up measurements
  6. 2-year post inclusion follow-up measurements
  7. 5- year post inclusion follow-up measurements

The control-group:

  1. Informed consent for the study
  2. After agreeing to being included, participants complete the set of questionnaires for base-line measures
  3. Treatment as usual, including two process-measurements of AADQ
  4. Post-intervention measurments
  5. 1-year post inclusion follow-up measurements
Conditions
Type 1 Diabetes
Being tested
Acceptance and Commitment Therapy (ACT)
Medical subject headings
Diabetes Mellitus, Type 1

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Acceptance and Commitment Therapy (ACT)Behavioural

    Also called Diabetes in Balance

    ACT is a specific form of Cognitive behavior therapy (CBT) which will be given as a course consisting of seven sessions where each session is two hours long.

Study groups in NCT02914496
Study groupRoleWhat they receive
Diabetes in BalanceExperimentalThe intervention consists of the manual-based CBT-group intervention "Diabetes in Balance". It is given in a group format with six to ten participants and consists of 7 sessions. The sessions are given bi-weekly for two hours. Each session has a specific theme such as "Stress and acceptance" "The life-compass; what is important in my life". The participants also conduct assignments related to the themes between the sessions. A licensed psychologist specialised in CBT and a diabetes specialist nurse, both trained in "ACT-stress management" will be leading the intervention group.
Receives: Behavioral: Acceptance and Commitment Therapy (ACT)
ControlNo interventionThe control group receives regular care including regular visits at the out-patient clinic, 3-4 times per year.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. HbA1c

    Measure of long term glucose control

    Measured: 12 months post inclusion

Secondary outcomes (6)
  1. Manchester Short Assessment of Quality of life

    A form with 16 questions that examines the quality of life and satisfaction with life in general , employment, economy, friendships , leisure , housing , personal safety, and Health.

    Measured: 1-5 years post inclusion

  2. Depression Anxiety stress scales

    21 questions measuring depression, anxiety and stress during the last week.

    Measured: 1-5 years post inclusion

  3. The Hypoglycemia Fear Survey emotions, depression, anxiety, fear of hypoglycemia, general and diabetes related distress.

    A 23-items self-assessment questionnaire that appreciates concerns and behaviors in relation to hypoglycaemia.

    Measured: 1-5 years post inclusion

  4. The Problem Areas in Diabetes (Swe-PAID-20) Scale

    A questionnaire that measures the perception of burden in relation to diabetes and its treatment.

    Measured: 1-5 years post inclusion

  5. Acceptance and action diabetes questionnaire

    A questionnaire ( 11 questions ) that measures the emotional and cognitive avoidance related to diabetes.

    Measured: 1-5 years post inclusion

  6. The Summary of Self-Care Activities

    An instrument that reflects self-care activities such as SMBG, healthy eating and the implementation of optimal insulin therapy.

    Measured: 1-5 years post inclusion

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Sep 2016 (estimated)
  2. Study start15 Oct 2016
  3. Primary completion30 Jun 2020
  4. Study completion31 Dec 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
81 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02914496
Sponsor's protocol ID
EPN Stockhom 2016/14-31/1
Status last verified
Jul 2025
First submitted
15 Sep 2016
Last updated
25 Jul 2025
Results posted
No
Data monitoring committee
No
Individual data sharing
No: Data will primarily be presented at the group level. Individual data will where appropriate be anonymised

Publications

  • Wijk I, Amsberg S, Johansson UB, Livheim F, Toft E, Anderbro T. Impact of an Acceptance and Commitment Therapy programme on HbA1c, self-management and psychosocial factors in adults with type 1 diabetes and elevated HbA1c levels: a randomised controlled trial. BMJ Open. 2023 Dec 14;13(12):e072061. doi: 10.1136/bmjopen-2023-072061.

    PubMed 38101850
  • Amsberg S, Wijk I, Livheim F, Toft E, Johansson UB, Anderbro T. Acceptance and commitment therapy (ACT) for adult type 1 diabetes management: study protocol for a randomised controlled trial. BMJ Open. 2018 Nov 28;8(11):e022234. doi: 10.1136/bmjopen-2018-022234.

    PubMed 30498037

Questions about this trial

What is this clinical trial studying?

A study testing Acceptance and Commitment Therapy (ACT) in people with Type 1 Diabetes, run by Karolinska Institutet at 1 site in Sweden.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 25 Jul 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Sweden. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

HbA1c (time frame: 12 months post inclusion). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02914496, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Jul 2025; AzTrials last refreshed its copy on 6 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in